BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10514474)

  • 1. Oligodendrocyte programmed cell death and central myelination deficiency induced in transgenic mice by synergism between c-Myc and Oct-6.
    Jensen NA; West MJ; Celis JE
    J Biol Chem; 1999 Oct; 274(42):29921-6. PubMed ID: 10514474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of central nervous system myelination in MBP/c-myc transgenic mice: evidence for c-myc cytotoxicity.
    Jensen NA; Pedersen KM; Celis JE; West MJ
    Oncogene; 1998 Apr; 16(16):2123-9. PubMed ID: 9572493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6.
    Jensen NA; Pedersen KM; Celis JE; West MJ
    J Clin Invest; 1998 Mar; 101(6):1292-9. PubMed ID: 9502770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic changes associated with degeneration of myelin-forming cells in the central nervous system of c-myc transgenic mice.
    Jensen NA; Celis JE
    Electrophoresis; 1998 Aug; 19(11):2014-20. PubMed ID: 9740063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes.
    Orian JM; Slavin A; Ayers MM; Bernard CC
    J Neurosci Res; 1997 Dec; 50(5):809-20. PubMed ID: 9418968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice.
    Xin M; Yue T; Ma Z; Wu FF; Gow A; Lu QR
    J Neurosci; 2005 Feb; 25(6):1354-65. PubMed ID: 15703389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region specific oligodendrocyte transcription factor expression in a model of neonatal hypoxic injury.
    Affeldt BM; Obenaus A; Chan J; Pardo AC
    Int J Dev Neurosci; 2017 Oct; 61():1-11. PubMed ID: 28546087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice.
    Skoff RP; Bessert DA; Barks JD; Song D; Cerghet M; Silverstein FS
    Int J Dev Neurosci; 2001 Apr; 19(2):197-208. PubMed ID: 11255033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.
    Potzner MR; Griffel C; Lütjen-Drecoll E; Bösl MR; Wegner M; Sock E
    Mol Cell Biol; 2007 Aug; 27(15):5316-26. PubMed ID: 17515609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of JC virus large T antigen with myelin basic protein transcription factor (MEF-1/Puralpha) in hypomyelinated brains of mice transgenically expressing T antigen.
    Tretiakova A; Otte J; Croul SE; Kim JH; Johnson EM; Amini S; Khalili K
    J Virol; 1999 Jul; 73(7):6076-84. PubMed ID: 10364361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of c-myc and CD45 in spontaneous and anti-receptor-induced apoptosis in adult murine B cells.
    Scott DW; Lamers M; Köhler G; Sidman CL; Maddox B; Carsetti R
    Int Immunol; 1996 Sep; 8(9):1375-85. PubMed ID: 8921415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
    Factor V; Oliver AL; Panta GR; Thorgeirsson SS; Sonenshein GE; Arsura M
    Hepatology; 2001 Jul; 34(1):32-41. PubMed ID: 11431731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed oligodendrocyte development and recovery from hypomyelination in a c-myc transgenic mouse mutant.
    Orian JM; Ahern AJ; Ayers MM; Levine JM; Tapp LD; Reynolds R
    J Neurosci Res; 2001 Oct; 66(1):46-58. PubMed ID: 11599001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
    Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
    Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression and oligodendrocyte development in the myelin deficient rat.
    Nadon NL; Duncan ID
    J Neurosci Res; 1995 May; 41(1):96-104. PubMed ID: 7674382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GFAP-positive and myelin marker-positive glia in normal and pathologic environments.
    Dyer CA; Kendler A; Jean-Guillaume D; Awatramani R; Lee A; Mason LM; Kamholz J
    J Neurosci Res; 2000 May; 60(3):412-26. PubMed ID: 10797544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter.
    Grinspan J; Wrabetz L; Kamholz J
    J Neurocytol; 1993 May; 22(5):322-33. PubMed ID: 7686214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of myc or myn down-regulates immunoglobulin transcription.
    Sigvardsson M; Johansson K; Larsson LG; Nilsson K; Leanderson T
    Leukemia; 1994 Jul; 8(7):1157-63. PubMed ID: 8035607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.
    Hashimoto M; Murata K; Ishida J; Kanou A; Kasuya Y; Fukamizu A
    J Biol Chem; 2016 Jan; 291(5):2237-45. PubMed ID: 26637354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.